CSafe launches transport packaging for gene therapy market

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story

Related Topics

Latest pharma logistics news

Bolloré’s contract logistics business grows with acquisition

Bolloré Logistics’ contract logistics subsidiary, Bolloré Solutions Logistiques (BSL) has acquired STEF Logistique Santé (SLS) to grow its contract logistics…

Read More

Share this story

Bangkok Flight Services gains GDP certification

Handler Bangkok Flight Services has achieved Good Distribution Practice (GDP) certification for its pharma facility at Suvarnabhumi International Airport. BFS,…

Read More

Share this story

Etihad Cargo reports record pharma volumes

Etihad Cargo reported record cargo volumes last year following investments in its cool chain services. The Abu Dhabi-headquartered airline saw…

Read More

Share this story

Damian Brett

Damian Brett
I have been writing about the freight and logistics industry since 2007 when I joined International Freighting Weekly to cover the shipping sector.After a stint in PR, I have gone on to work for Containerisation International and Lloyds List - where I was editor of container shipping - before joining Air Cargo News in 2015.Contact me on [email protected]